Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Metropolis Healthcare Ltd

METROPOLIS.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Healthcare Facilities & Services ·

India Small Cap Analyst: BUY

Last Close

$5.72

▼ -2.33%

Market Cap $1.19B · Vol 242.03K

Key Metrics

P/E Ratio

56.18

FWD: 40.15

Market Cap

$1.19B

Small Cap

Div Yield

0.55%

Thrice yearly

EPS Growth

+29.07%

YoY

RSI (14)

36.67

Momentum

Beta

0.77

vs Market

52W High

$6.38

11.05% below

52W Low

$4.32

30.20% above

Volume

242.03K

Avg 276.68K

P/B

5.95

Price-to-book

ROE

13.99%

Return on equity

Free Float

51.15%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Metropolis Healthcare Ltd (METROPOLIS.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does METROPOLIS.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-3.14%

-2.45%

+0.89%

+12.02%

YTD

+13.12%

+2.86%

+41.08%

-18.57%

Financials & Valuation

TTM · Annual

Total Revenue	$176.11M
Net Income	$20.46M
Revenue Growth (YoY)	+16.62%
Gross Margin	70.61%
Operating Margin	16.27%
Net Profit Margin	11.62%
ROE	13.99%
ROA · ROIC	12.94% · 12.63%

P/E Ratio	56.18
Forward P/E (FY1)	40.15
PEG Ratio	1.54
P/S	5.45
P/B	5.95
P/FCF	32.40
EPS Growth	+29.07%
Outstanding Shares	207.39M

Technical Indicators

50-Day SMA	$5.84
200-Day SMA	$5.25
RSI (14)	36.67
Beta	0.77
52-Week High	$6.38
52-Week Low	$4.32

Volume Today	242.03K
Avg Daily Volume (30D)	276.68K
Relative Volume	0.87x
Volatility (10D)	26.80
Volatility (30D)	33.48
Free Float	51.15%

Analyst Consensus

BUY

Current Price $5.72

Mean Target $6.84

52W Low$4.32 52W High$6.38

Current

Target

$4.32 $6.38

Current Analyst target

+19.72% upside potential · 18 analysts

Identifiers

ExchangeNSE India

FIGIBBG001SPC7C9

ISININE112L01020

CountryIndia

Sub-IndustryMedical & Diagnostic Laboratories

Earnings DateNov 2, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

NTRA Natera Inc -0.27% LH Labcorp Holdings Inc -1.38% RDNT RadNet Inc -1.24% LALPATHLAB.NS Dr. Lal PathLabs Ltd -2.65% WGS GeneDx Holdings Corp -1.35%

Company Profile

Metropolis Healthcare Limited is engaged in providing diagnostic services to patients, healthcare providers, and corporates across India and Africa. It has a single operating segment, namely Pathology services. It is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, other pathological and radiological investigations. Its services include Pathology Testing Services, Corporate Wellness, Lab In Hospitals and Clinical Research Services. It serves a diverse customer base, including B2C (Business to Consumer), B2B (Business to Business), and institutional clients. It offers more than 4,000 tests and profiles, including advanced tests for diagnosing cancer, neurological disorders, infectious diseases, and various genetic abnormalities. Its footprint spans 28 states, seven Union Territories.